C

CellCentric

12 employees

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2003

Funding rounds raised

Total raised

$33M

from 13 investors over 13 rounds

C

CellCentric raised undisclosed on January 26, 2022

Investors: Morningside Venture Partners

C

CellCentric raised $33M on October 22, 2020

Investors: Morningside Venture Capital 晨兴资本

C

CellCentric raised $26M on May 15, 2018

Investors: Morningside Venture Partners

C

CellCentric raised undisclosed on June 1, 2017

Investors: Nesta

C

CellCentric raised undisclosed on November 8, 2016

Investors: Innovate UK

C

CellCentric raised undisclosed on October 19, 2015

Investors: Morningside Venture Partners

C

CellCentric raised $6.7M on June 25, 2013

Investors: Morningside Venture Capital 晨兴资本, UK Innovation & Science Seed Fund and Future Planet Capital

C

CellCentric raised undisclosed on August 1, 2012

Investors: Future Planet Capital

C

CellCentric raised undisclosed on March 14, 2011

Investors: Morningside Venture Partners and Takeda UK Limited

C

CellCentric raised $650K on May 10, 2010

Investors: BBSRC

FAQ